Muscle-Related Temporomandibular Disorders

Journal of Orofacial Pain

Volumn 13, Issue 4, 1999, Pages 273-284

  Stohler, Christian S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Allodynia; Autonomic system; Gender differences; Neuroendocrine system; Neuroplasticity; Sensitization

Indexed keywords

ARTHRALGIA; FACE PAIN; FEMALE; FIBROMYALGIA; HUMAN; INNERVATION; MALE; MASTICATORY MUSCLE; MYOFASCIAL PAIN; NERVE CELL PLASTICITY; NERVE TRACT; NOCICEPTIVE RECEPTOR; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; REVIEW; SEX DIFFERENCE;

ARTHRALGIA; FACIAL PAIN; FEMALE; FIBROMYALGIA; HUMANS; MALE; MASTICATORY MUSCLES; NEURAL PATHWAYS; NEURONAL PLASTICITY; NOCICEPTORS; PREVALENCE; SEX FACTORS; TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME;

EID: 0033186820     PISSN: 10646655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Dworkin SF, LeResche L. Research Diagnostic Criteria for Temporomandibular Disorders: Review, Criteria, Examinations and Specifications, Critique. J Craniomandib Disord Facial Oral Pain 1992;6:301-355.
2. Huggins KH, Dworkin SF, Saunders K, Von Korff M, Barlow W. Five-year course for temporomandibular disorders using RDC/TMD [abstract]. J Dent Res 1996;75:352.
3. Turp JC, Kowalski CJ, Stohler CS. Temporomandibular disorders - Pain outside the head and face is rarely acknowledged in the chief complaint. J Prosthet Dent 1997;78:592-595.
4. Turp JC, Kowalski CJ, O'Leary TJ, Stohler CS. Pain maps from facial pain patients indicate a broad pain geography. J Dent Res 1998;77:1465-1472.
5. Travell JG, Simons DG. Myofascial Pain and Dysfunction. The Trigger Point Manual. The Upper Extremities, vol 1. Baltimore: Williams & Wilkins, 1983.
6. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-172.
7. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
8. Aaron LA, Bradley LA, Alarcon GS, Alexander RW, Triana-Alexander M, Martin MY, Alberts KR. Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheumatism 1996;39:436-445.
9. Goldenberg DL. Management of fibromyalgia syndrome. Rheum Dis Clin North Am 1989;15:499-512.
10. Plesh O, Wolfe F, Lane N. The relationship between fibromyalgia and temporomandibular disorders: Prevalence and symptom severity. J Rheumatol 1996;23:1948-1952.
11. Hedenberg-Magnusson B, Ernberg M, Kopp S. Symptoms and signs of temporomandibular disorders in patients with fibromyalgia and local myalgia of the temporomandibular system. A comparative study. Acta Odontol Scand 1997;55:344-349.
12. Korszun A, Papadopoulos E, Demitrack M, Engleberg C, Crofford L. The relationship between temporomandibular disorders and stress-associated syndromes. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:416-420.
13. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria of headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8:1-96.
14. Unruh AM. Gender variations in clinical pain experience [review]. Pain 1996;65:123-167.
15. Agerberg G, Carlsson GE. Functional disorders of the masticatory system. II. Symptoms in relation to impaired mobility of the mandible as judged from investigation by questionnaire. Acta Odontol Scand 1973;31:337-347.
16. Magnusson T, Carlsson GE. Changes in recurrent headaches and mandibular dysfunction after various types of dental treatment. Acta Odontol Scand 1980; 38:311-320.
17. Forssell H, Kangasniemi P. Mandibular dysfunction in patients with migraine. Proc Finn Dent Soc 1984; 80:217-222.
18. Forssell H, Kangasniemi P. Mandibular dysfunction in patients with muscle contraction headache. Proc Finn Dent Soc 1984;80:211-216.
19. Hiltunen K, Schmidt-Kaunisaho K, Nevalainen J, Narhi T. Ainamo A. Prevalence of signs of temporomandibular disorders among elderly inhabitants of Helsinki, Finland. Acta Odontol Scand 1995;53:20-23.
20. Von Korff M, Dworkin SF, Le Resche L, Kruger A. An epidemiologic comparison of pain complaints. Pain 1988;32:173-183.
21. Von Korff M, Wagner EH, Dworkin SF, Saunders KW. Chronic pain and use of ambulatory health care. Psychosom Med 1991;53:61-79.
22. LeResche L, Saunders K, Von KM, Barlow W, Dworkin SF. Use of exogenous hormones and risk of temporomandibular disorder pain. Pain 1997;69:153-160.
23. Solberg WK, Woo MW, Houston JB. Prevalence of mandibular dysfunction in young adults. J Am Dent Assoc 1979;98:25-34.
24. Riolo ML, Brandt D, Ten Have TR. Associations between occlusal characteristics and signs and symptoms of TMJ dysfunction in children and young adults. Am J Orthod Dentofacial Orthop 1987;92:467-477.
25. Pilley JR, Mohlin B, Shaw WC, Kingdon A. A survey of craniomandibular disorders in 800 15-year-olds. A followup study of children with malocclusion. Eur J Orthod 1992;14:152-161.
26. List T, Dworkin SF. Comparing TMD diagnoses and clinical findings at Swedish and US TMD centers using research diagnostic criteria for temporomandibular disorders. J Orofac Pain 1996;10:240-253.
27. Lipton JA, Ship JA, Larach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. J Am Dent Assoc 1993;124:115-121.
28. Pellegrino MJ, Waylonis GW, Sommer A. Familial occurrence of primary fibromyalgia. Arch Phys Med Rehabil 1989;70:61-63.
29. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527-1531.
30. Sessle BJ. The neural basis of temporomandibular joint and masticatory muscle pain. J Orofac Pain 1999;13:238-245.
31. Schaible HG. On the role of tachykinins and calcitonin gene-related peptide in the spinal mechanisms of nociception and in the induction and maintenance of inflammation-evoked hyperexcitability in spinal cord neurons (with special reference to nociception in joints) [review]. Prog Brain Res 1996;113:423-441.
32. Kinnman E, Levine JD. Involvement of the sympathetic postganglionic neuron in capsaicin-induced secondary hyperalgesia in the rat. Neuroscience 1995;65:283-291.
33. Schafer M, Carter L, Stein C. Interleukin-1 beta and corticotropin-rcleasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA 1994;91:4219-4223.
34. Przewlocki R, Hassan AH, Lason W, Epplen C, Herz A, Stein C. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: Functional role in antinociception. Neuroscience 1992;48:491-500.
35. Andreev NY, Dimitrieva N, Koltzenburg M, McMahon SB. Peripheral administration of nerve growth factor in the adult rat produces a thermal hyperalgesia that requires the presence of sympathetic post-ganglionic neurons. Pain 1995;63:109-115.
36. Lewin GR, Rueff A, Mendell LM. Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur J Neurosci 1994;6:1903-1912.
37. Aloe L, Skaper SD, Leon A, Levi-Montalcini R. Nerve growth factor and autoimmune diseases. Autoimmunity. 1994;19:141-150.
38. Petty BG, Cornblath DR, Adornato BT, Chaudhry V, Flexner C, Wachsman M, et al. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol 1994;36:244-246.
39. Sohrabji F, Miranda RC, Toran-Allerand CD. Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J Neurosci 1994;14:459-471.
40. Woolf CJ, Walters ET. Common patterns of plasticity contributing to nociceptive sensitization in mammals and aplysia. Trends Neurosci 1991;14:74-78.
41. Sessle BJ, Hu JW, Amano N, Zhong G. Convergence of cutaneous, tooth pulp, visceral, neck and muscle afferents onto nociceptive and non-nociceptive neurones in trigeminal subnucleus caudalis (medullary dorsal horn) and its implications for referred pain. Pain 1986;27:219-235.
42. Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994;37:1593-1601.
43. Mense S, Hoheisel U, Reinert A. The possible role of substance P in eliciting and modulating deep somatic pain [review]. Prog Brain Res 1996;110:125-135.
44. Ruda MA, Dubner R. Molecular and biochemical events mediate neuronal plasticity following inflammation and hyperalgesia. In: Willis WD Jr (ed). Hyperalgesia and Allodynia. New York: Raven Press, 1992:311-325.
45. Hu JW, Yu XM, Vernon H, Sessle BJ. Excitatory effects on neck and jaw muscle activity of inflammatory irritant applied to cervical paraspinal tissues. Pain 1993; 55:243-250.
46. Hoheisel U, Sander B, Mense S. Myositis-induced functional reorganisation of the rat dorsal horn: Effects of spinal superfusion with antagonists to neurokinin and glutamate receptors. Pain 1997;69:219-230.
47. Gracely RH, Dubner R, McGrath PA. Narcotic analgesia: Fentanyl reduces the intensity but not the unpleasantness of painful tooth pulp sensations. Science 1979; 203:1261-1263.
48. Levine JD, Gordon NC, Jones RT, Fields HL. The narcotic antagonist naloxone enhances clinical pain. Nature 1978;272:826-827.
49. Gracely RH, Dubner R, Wolskee PJ, Deeter WR. Placebo and naloxone can alter post-surgical pain by separate mechanisms. Nature 1983;306:264-265.
50. Sharma HS, Nyberg F, Olsson Y, Dey PK. Alteration of substance P after trauma to the spinal cord: An experimental study in the rat. Neuroscience 1990;38:205-212.
51. Eide PK, Hole K. Interactions between serotonin and substance P in the spinal regulation of nociception. Brain Res 1991;550:225-230.
52. Almay BG, Johansson F, von Knorring L, Le Greves P, Terenius L. Substance P in CSF of patients with chronic pain syndromes. Pain 1988:33:3-9.
53. Layzer RB. Muscle pain, cramps, and fatigue. In: Engel AG, Franzini-Armstrong C (eds). Myology: Basic Clinical, ed 2. New York : McGraw-Hill, 1994:1754-1768.
54. Merskey H. Pain terms: A current list with definitions and notes on usage. Pain 1999;82:S216-S221.
55. Casey KL. Nociceptors and their sensitization. In: Willis WD (ed). Hyperalgesia and Allodynia. New York: Raven Press, 1992:13-15.
56. Stohler CS, Kowalski CJ. Spatial and temporal summation of sensory and affective dimensions of deep somatic pain. Pain 1999;79:165-173.
57. Jacobsen S, Petersen IS, Danneskiold-Samsoe B. Clinical features in patients with chronic muscle pain - with special reference to fibromyalgia. Scand J Rheumatol 1993;22:69-76.
58. Tunks E, Crook J, Norman G, Kalaher S. Tender points in fibromyalgia. Pain 1988;34:11-19.
59. Mikkelsson M, Latikka P, Kautiainen H, Isomeri R, Isomaki H. Muscle and bone pressure pain threshold and pain tolerance in fibromyalgia patients and controls. Arch Phys Med Rehabil 1992;73:814-818.
60. Lund JP, Donga R, Widmer CG, Stohler CS. The painadaptation model: A discussion of the relationship between chronic musculoskeletal pain and motor activity. Can J Physiol Pharmacol 1991;69:683-694.
61. Schwartz G, Lund JP. Modification of rhythmical jaw movements by noxious pressure applied to the periosteum of the zygoma in decerebrate rabbits. Pain 1995; 63:153-161.
62. Obrez A, Stohler CS. Jaw muscle pain and its effect on gothic arch tracings. J Prosthet Dent 1996;75:393-398.
63. Von Korff M, Ormel J, Katon W, Lin EH. Disability and depression among high utilizers of health care. A longitudinal analysis. Arch Gen Psych 1992;49:91-100.
64. Fernandez E, Milburn TW. Sensory and affective predictors of overall pain and emotions associated with affective pain. Clin J Pain 1994;10:3-9.
65. Sofaer B, Walker J. Mood assessment in chronic pain patients. Disabil Rehabil 1994;16:35-38.
66. Simerly RB, Chang C, Muramatsu M, Swanson LW. Distribution of androgen and estrogcn receptor mRNA-containing cells in the rat brain: An in situ hybridization study. J Comp Neurol 1990;294:76-95.